Daihan Pharmaceutical Revenue

In the year 2024, Daihan Pharmaceutical had annual revenue of 204.19B KRW with 4.23% growth. Daihan Pharmaceutical had revenue of 51.44B in the quarter ending December 31, 2024, with 4.51% growth.

Revenue

204.19B

Revenue Growth

+4.23%

P/S Ratio

0.73

Revenue / Employee

369.25M

Employees

553

Market Cap

148.47B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	204.19B	8.28B	4.23%
Dec 31, 2023	195.91B	11.64B	6.32%
Dec 31, 2022	184.27B	12.80B	7.47%
Dec 31, 2021	171.46B	5.38B	3.24%
Dec 31, 2020	166.08B	-2.68B	-1.59%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Electronics	300.87T
SK hynix	66.19T
LG Energy Solution	25.62T
Samsung Biologics	4,547.32B
Hyundai Motor Company	175.23T
Celltrion	3,557.30B
Kia Corporation	107.45T
KB Financial Group	15.01T

Revenue Rankings